Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
John Lee is an analyst at Truist Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/05/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/18/2024 | ANAB | Buy Now | AnaptysBio | $18.50 | 8.11% | John Lee1% | $30 → $20 | Maintains | Hold | Get Alert |
| 08/15/2024 | ANAB | Buy Now | AnaptysBio | $18.50 | 62.16% | John Lee1% | $20 → $30 | Maintains | Hold | Get Alert |
| 09/13/2022 | ANAB | Buy Now | AnaptysBio | $18.50 | 51.35% | John Lee1% | $50 → $28 | Downgrade | Buy → Hold | Get Alert |
| 01/31/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | John Lee1% | — | Downgrade | Buy → Hold | Get Alert |
